vimarsana.com
Home
Live Updates
THERANEXUS: Theranexus and BBDF finalize recruitment for pha
THERANEXUS: Theranexus and BBDF finalize recruitment for pha
THERANEXUS: Theranexus and BBDF finalize recruitment for phase I/II trial to evaluate Batten-1 in Batten disease
Lyon, France - Austin, Texas, United States - 8 September 2022 - 6 pm CEST - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development
Related Keywords
United States ,
Houston ,
Texas ,
Paris ,
France General ,
France ,
French ,
Gary Clark ,
Craig Benson ,
Thierry Lambert ,
Florence Portejoie ,
Martin Pierre Laurent ,
Franck Mouthon ,
National Organization For Rare Disorders ,
Twitter ,
Atomic Energy Commission ,
Batten Disease Foundation ,
Beyond Batten Disease Foundation ,
Child Neurology ,
Texas Children ,
French Alternative Energies ,
Euronext Growth ,
Rare Disorders ,
Theranexus ,
Bbdf ,
Finalize ,
Recruitment ,
Hase ,
Trial ,
Valuate ,
Thatten ,
Disease ,